Pneumoccoccal Immunisation research hub

C4931004 - A Phase 3, Randomized Double-Blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Catch-Up Vaccination Regimen of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Children and Adolescents

This study looks at a vaccine called Prevenar 20 in healthy children and teenagers aged 15 months to 17 years. Researchers want to see how safe the vaccine is and how well it helps the body build protection against bacteria that cause ear infections, chest infections, and meningitis.